Caption

Dunwoody Country Club gives Emory $265K for prostate cancer research

A metro-Atlanta group is helping fund more research for prostate cancer.

The Senior Men of Dunwoody Country Club, has raised $265K for Emory’s Winship Cancer Institute. David Andersen, fundraising chairman of the club also known as the Champions Golf Association, explained the money will help start new research projects.

“This funding by the Champions has a multiplier effect, whereby successful pilot studies funded by the Champions receive federal grants to further support the testing of new approaches to detecting and managing prostate cancer,” Andersen said.


 MORE: 13 movie, TV projects have filmed at Emory University in 2018

Recommended for you

Recommended for you

Recommended for you

Most read

  1. 1 Black ice possible Tuesday morning; state offices delay opening
  2. 2 Gwinnett real estate agent to serve prison time for $22M fraud scheme
  3. 3 ‘This has broken us totally apart’: 2 cousins shot dead in DeKalb home

Money raised by the Champions association will be matched by Winship Cancer Institute, bringing the total money for research to $530K.

In a press release, Walter Curran, executive director of the institute, explained that the fundraising money allows for more of their researchers to “explore novel ideas which would not otherwise qualify for funding.”

Dunwoody Country Club has contributed $1.3 million directly to Winship Institute since 2010, according to the release.

Prostate cancer is the most common cancer among men (after skin cancer), according to the American Cancer Society. About 1 in 9 men will be diagnosed with prostate cancer during their lifetime. This year, about 164,700 new cases of prostate cancer will be diagnosed, and about 29,400 people will die from the disease.


Like DeKalb County News Now on Facebook | Follow on Twitter

In other health news:

According to a new study, thousands of women with early-stage breast cancer may be able to skip chemotherapy. The study was published June 3 in the New England Journal of Medicine. Researchers found that most patients with an intermediate risk of cancer recurrence can skip chemotherapy treatment. The study was funded by the National Cancer Institute, various foundations and proceeds from the breast cancer research stamp. It's the largest ever study done on breast cancer treatment.

More from AJC